Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, Agnieszka K., McMillan, Elizabeth A., Balaji, Uthra, Baek, GuemHee, Lin, Wan-Chi, Mansour, John, Mollaee, Mehri, Wagner, Kay-Uwe, Koduru, Prasad, Yopp, Adam, Choti, Michael A., Yeo, Charles J., McCue, Peter, White, Michael A., Knudsen, Erik S.·2015·Nature Communications

DOI 10.1038/ncomms7744

Cited by (1,000)

Items 501–600 of 1,000

Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer
Huaqing Shi, Hao Ming Xu, Changpeng Chai, Zishun Qin, Wence Zhou · 2022 · Journal of Clinical Laboratory Analysis
Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer
Isis J. Visser, Iris J. M. Levink, Maikel Petrus Peppelenbosch, Gwenny Manel Fuhler, Marco J. Bruno, Djuna L. Cahen · 2022 · Pancreatology
Co-occurring IPMN and pancreatic cancer: the same or different? An overview from histology to molecular pathology
Yuko Omori, Toru Furukawa, Aldo Scarpa, Claudio Luchini · 2023 · Journal of Clinical Pathology
Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas
Sameer Abdallah Dhayat, Zixuan Yang · 2020 · Journal of Cancer Research and Clinical Oncology
The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
Yefan Yang, Ying Ding, Yuxi Gong, Sha Zhao, Mingna Li, Xiao Li, Guoxin Song, Boya Zhai, Jin Liu, Yang Washington Shao et al. · 2022 · BMC Cancer
Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216
Beatrice Mohelníková-Duchoňová, Matěj Kočík, B. Mohelníkova Duchonova, Veronika Brynychová, Martin Oliverius, Jan Hlavsa, Eva Honsová, Jan Mazanec, Zdeněk Kala, Iwao Ojima et al. · 2016 · The Pharmacogenomics Journal
DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
Meng-Chen Tsai, Wei‐Ming Li, Chun‐Nung Huang, Hung‐Lung Ke, Ching‐Chia Li, Hsin‐Chih Yeh, Ti‐Chun Chan, Peir‐In Liang, Bi‐Wen Yeh, Wen‐Jeng Wu et al. · 2016 · Oncotarget
A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model
Sangkyu Park, Dongbum Kim, Guang Jer Wu, Harry Jung, Jeong-A Park, Hyung‐Joo Kwon, Younghee Lee · 2018 · OncoTargets and Therapy
Correction to: Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography-based radiomics and genetic alterations of pancreatic ductal adenocarcinoma
Chae Hong Lim, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Ji Hye Min, Seung Hyup Hyun · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance
Xintong Zhang, Yaru Du, Axel Behrens, Linxiang Lan · 2025 · Developmental Cell
The molecular landscape of pancreatic ductal adenocarcinoma
Lavanya Sivapalan, Hemant Mahendrakumar Kocher, Helen Ross‐Adams, Claude Chelala · 2022 · Pancreatology
Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies
Sajid Ullah Khan, Vivekananda Budamagunta, Daohong Zhou · 2023 · Advances in cancer research
Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer
Nirakar Rajbhandari, Michael Hamilton, Cynthia M Quintero, Lesley Paige Ferguson, Raymond G. Fox, Christian M. Schürch, Jun Wang, Mari Nakamura, Nikki K. Lytle, Matthew L. McDermott et al. · 2023 · Cancer Cell
MicroRNAs Targeting MYC Expression: Trace of Hope for Pancreatic Cancer Therapy. A Systematic Review
Roshanak Shams, Hamid Asadzadeh Aghdaei, Ali Behmanesh, Amir Sadeghi, Mohammadreza Zali, Sina Salari, José M Padrón · 2020 · Cancer Management and Research
Whole Exome Sequencing of Biliary Tubulopapillary Neoplasms Reveals Common Mutations in Chromatin Remodeling Genes
Claudia Gross, Thomas Engleitner, Sebastian Lange, Julia Weber, Moritz Jesinghaus, Björn Konukiewitz, Alexander Muckenhuber, Katja Steiger, Nicole Pfarr, Benjamin Frank Goeppert et al. · 2021 · Cancers
Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review
Joanne Lundy, Owen McKay, Daniel Croagh, Vinod Ganju · 2022 · JCO Precision Oncology
KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents
Irene Ischenko, Jizu Zhi, Michael J. Hayman, Oleksi Petrenko · 2017 · Oncotarget
Utility of “liquid biopsy” using pancreatic juice for early detection of pancreatic cancer
Tetsuhiro Okada, Hirotoshi Iwano, Yusuke Ono, Hidenori Karasaki, Takayuki Sato, Masataka Yamada, Yuko Omori, Hiroki Sato, Akihiro Hayashi, Hidemasa Kawabata et al. · 2018 · Endoscopy International Open
RBM10 regulates human TERT gene splicing and inhibits pancreatic cancer progression.
Wenjing Xiao, Xin Chen, Xia Li, Kaiwen Deng, Huawei Liu, Jie Ma, Zhanhao Wang, Yonghe Hu, Jun Hou · 2021 · PubMed Central
Advances in Vaccine-Based Therapies for Pancreatic Cancer
Matthew T. McMillan, Kevin C. Soares · 2025 · Journal of Gastrointestinal Cancer
From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers
Ioannis D. Kyrochristos, G. Glantzounis, D. Ziogas, Ioannis Gizas, D. Schizas, E. Lykoudis, E. Felekouras, A. Machairas, C. Katsios, T. Liakakos et al. · 2017 · International Journal of Molecular Sciences
Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes
Junliang Lu, Ruoying Yu, Rui Liu, Xiaolong Liang, Jian Hua Sun, Hui Zhang, Huanwen Wu, Zhiwen Zhang, Yang Washington Shao, Junchao Guo et al. · 2020 · Cancer Medicine
Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care
Ahmad B. Hamad, Zachary J. Brown, Aslam M. Ejaz, Mary E. Dillhoff, Jordan M. Cloyd · 2021 · World Journal of Gastroenterology
Mitogen Synergy: An Emerging Route to Boosting Human Beta Cell Proliferation
E. G. Shcheglova, Katarzyna Błaszczyk, Malgorzata Borowiak · 2022 · Frontiers in Cell and Developmental Biology
Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma
Udo Rudloff · 2022 · Expert Opinion on Emerging Drugs
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective
Timofey D. Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan, Li X · 2023 · Cells
Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)
Joshua H. Zhang, Lily Darman, Md Sazzad Hassan, Urs W. von Holzen, Niranjan Awasthi · 2023 · Oncology Reports
The diagnostic utility of methylthioadenosine phosphorylase immunohistochemistry for pancreatic ductal adenocarcinoma in FNA and small biopsy specimens
Sanhong Yu, Leona A. Doyle, Jason L. Hornick, Jeffrey K. Mito · 2023 · Cancer Cytopathology
Molecular Genetics of Pancreatic Neoplasms
Waki Hosoda, Laura DeLong Wood · 2016 · Surgical pathology clinics
Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma
Lauren C. Cutmore, Nicholas Fraser Brown, D. Raj, S. Chauduri, Peking Wang, John F. Maher, Y Wang, Nicholas Robert Lemoine, John F. Marshall · 2020 · Pancreatology
Comprehensive Investigation into the Role of Ubiquitin-Conjugating Enzyme E2S in Melanoma Development
Ping Wang, Yong Li, Yangyang Ma, Xiaoyan Zhang, Li Zhao, Wenzhong Yu, Mengyan Zhu, Jiaqi Wang, Yongping Xu, Aie Xu · 2020 · Journal of Investigative Dermatology
A Fucoxanthinol Induces Apoptosis in a Pancreatic Intraepithelial Neoplasia Cell
Masaru Terasaki, Takuya Inoue, Wataru Murase, Atsuhito Kubota, Hiroyuki Kojima, M. Kojoma, Tohru Ohta, Hayato Maeda, K. Miyashita, M. Mutoh et al. · 2021 · Cancer Genomics & Proteomics
Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model
Yang Gao, Enchong Zhang, Xiang Fei, Lingming Kong, Peng Liu, Xiaodong Tan · 2021 · Frontiers in Cell and Developmental Biology
Molecular basis of epigenetic regulation in cancer diagnosis and treatment
Sonam Tulsyan, Mehreen Aftab, Sandeep Sisodiya, Asiya Khan, Atul Chikara, Pranay Tanwar, Showket Hussain · 2022 · Frontiers in Genetics
Findings made in gene panel to whole genome sequencing: data, knowledge, ethics – and consequences?
Eva Caroline Winkler, Stefan Wiemann · 2016 · Expert Review of Molecular Diagnostics
Advances in DNA/RNA Sequencing and Their Applications in Acute Myeloid Leukemia (AML)
Fatimah Ahmed, Jiang F. Zhong · 2024 · International Journal of Molecular Sciences
Deep sequencing reveals the genomic characteristics of lung adenocarcinoma presenting as ground-glass nodules (GGNs)
Nan Wu, Sixue Liu, Jingjing Li, Zhenyu Hu, Shi Yan, Hongwei Duan, Dafei Wu, Yuanyuan Ma, Shaolei Li, Xing Wang et al. · 2021 · Translational Lung Cancer Research
Current Pathology Model of Pancreatic Cancer
K Szymoński, Katarzyna Milian-Ciesielska, Ewelina W. Lipiec, Dariusz Adamek · 2022 · Cancers
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma
Samantha Z. Brown, Grace A. McCarthy, James R. Carroll, Roberto Di Niro, Carl Pelz, Aditi Jain, Thomas Lee Sutton, Hannah D. Holly, Avinoam Nevler, Christopher William Schultz et al. · 2022 · Molecular and Cellular Biology
Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer
Niklas Krebs, Lukas Klein, Florian Wegwitz, Elisa Espinet, H. Carlo Maurer, Mengyu Tu, Frederike Penz, Stefan Küffer, Xingbo Xu, Hanibal Bohnenberger et al. · 2022 · JCI Insight
Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development
Carline Chaves-Almagro, Johanna Auriau, Alizée Dortignac, Pascal Clerc, Hubert Lulka, Simon Deleruyelle, Fabrice Projetti, Jessica Nakhlé, Audrey Francès, Judit Berta et al. · 2022 · International Journal of Molecular Sciences
Chromosomal instability-associated MAT1 lncRNA insulates MLL1-guided histone methylation and accelerates tumorigenesis
Hui Pan, Huixue Wang, Xiaoyu Zhang, Fan Yang, Xianqun Fan, He Zhang · 2022 · Cell Reports
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
Tatjana Arsenijevic, Katia Coulonval, Eric Raspé, Anne Demols, Pierre P. Roger, Jean‐Luc Van Laethem · 2023 · Cancers
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications
Zhiming Zhao, Xiaomo Li, Fei Wang, Yong Xu, Si Liu, Quanli Han, Zhiying Yang, Weiwei Huang, Zhuzeng Yin, Qu Liu et al. · 2023 · Cancer Medicine
Pancreatic Cancer and Detection Methods
Umbhorn Ungkulpasvich, Hideyuki Hatakeyama, Takaaki Hirotsu, Eric di Luccio · 2023 · Biomedicines
Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC
Angel A. Dominguez, M Perz, Yi Xu, Leonor G. Cedillo, O L Huang, Caitlin A. McIntyre, Vignesh Vudatha, Jose Gilberto Trevino, Jun Liu, Pei Wang · 2024 · Cancers
Crossroad between linear and nonlinear transcription concepts in the discovery of next-generation sequencing systems-based anticancer therapies
Dimitrios H Roukos · 2016 · Drug Discovery Today
Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells
Vegard Tjomsland, Monica Aasrum, Thoralf Christoffersen, Ivar P. Gladhaug · 2017 · Oncotarget
A screen for inducers of bHLH activity identifies pitavastatin as a regulator of p21, Rb phosphorylation and E2F target gene expression in pancreatic cancer
Nicholas Villarino, Lia Signaevskaia, Jaco van Niekerk, Rachel Medal, Heejung Kim, Reyhaneh Lahmy, Kathleen M. Scully, Anthony B. Pinkerton, Sang Wun Kim, Andrew M. Lowy et al. · 2017 · Oncotarget
Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling
Teresa Starzyñska, Jakub Karczmarski, Agnieszka Paziewska, Maria Kulecka, Katarzyna Kuśnierz, Natalia Żeber‐Lubecka, Filip Ambrożkiewicz, Michał Mikuła, Beata Kos‐Kudła, Jerzy Ostrowski · 2020 · International Journal of Molecular Sciences
miR24–3p activity after delivery into pancreatic carcinoma cell lines exerts profound tumor-inhibitory effects through distinct pathways of apoptosis and autophagy induction
Hannes Borchardt, Alexander Ewe, Markus Morawski, Ulrike Weirauch, Achim Michael Aigner · 2021 · Cancer Letters
The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma
Lin Shui, Xiaofen Li, Yang Peng, Jiangfang Tian, Shuangshuang Li, Du He, Ang Li, Bole Tian, Li Mao, Heli Gao et al. · 2021 · Journal of Translational Medicine
Rationale for MYC imaging and targeting in pancreatic cancer
Günter Schneider, Matthias Wirth, Ulrich Bernd Keller, Dieter Saur · 2021 · EJNMMI Research
Fucoxanthin Prevents Pancreatic Tumorigenesis in C57BL/6J Mice That Received Allogenic and Orthotopic Transplants of Cancer Cells
Wataru Murase, Yukino Kamakura, Serina Kawakami, Ayaka Yasuda, Momoka Wagatsuma, Atsuhito Kubota, Hiroyuki Kojima, Tohru Ohta, Mami Takahashi, Michihiro Mutoh et al. · 2021 · International Journal of Molecular Sciences
Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes
Musalula Sinkala, Nicola Mulder, Darren Patrick Martin · 2018 · Oncotarget
Carcinosarcoma of the pancreas: comprehensive clinicopathological and molecular characterization
Jin Li, Tao Wei, Jian Zhang, Shumei Wei, Qi Chen, Bryan Wei Chen, Yue Zhou, Liang Wen, Hao Qin, Xueli Bai et al. · 2020 · HPB
Treatment of KRAS-Mutant Non–Small Cell Lung Cancer
Jacob M. Kaufman, Thomas E. Stinchcombe · 2017 · JAMA
Pancreatic Adenosquamous Carcinoma: A Rare Pathological Subtype of Pancreatic Cancer
Qunli Xiong, Zhiwei Zhang, Yongfeng Xu, Qing Zhu · 2022 · Journal of Clinical Medicine
Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model
Concetta Panebianco, Federica Pisati, Annacandida Villani, Annapaola Andolfo, Marynka Ulaszewska, Edoardo Niccolò Bellini, Carmela Pia Ferro, Renato Lombardi, Fabrizio Orsenigo, Tiziana Pia Latiano et al. · 2023 · Cell Death Discovery
Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21
Maria Mortoglou, Francesc Miralles, Rhys Richard Mould, Dipankar Sengupta, Pinar Uysal Onganer · 2023 · European Journal of Cell Biology
The role of molecular testing in pancreatic cancer
David Bing Zhen, Rachael Ann Safyan, Eric Q. Konick, Ryan Nguyen, C. C. Pritchard, Elena Gabriela Chiorean · 2023 · Therapeutic Advances in Gastroenterology
Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response
Rebekah Crake, Imène Gasmi, Jordan Dehaye, Fanny Lardinois, Raphaël Peiffer, Naïma Maloujahmoum, Ferman Agirman, Benjamin Koopmansch, Nicky D’Haene, Oier Azurmendi Senar et al. · 2023 · Cells
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Brandon M. Huffman, Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S. Kapner, Bose S. Kochupurakkal, David B. Martignetti, Golbahar Sadatrezaei, Thomas Adam Abrams, Leah H. Biller et al. · 2023 · Clinical Cancer Research
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer
Meredith LaRose, Gulam Abbas Manji, Susan Elaine Bates · 2023 · Seminars in Oncology
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells
Stefania Moz, Daniela Basso, Dania Bozzato, Paola Galozzi, Filippo Navaglia, Ola H. Negm, Giorgio Arrigoni, Carlo‐Federico Zambon, Andrea Padoan, Patrick J. Tighe et al. · 2016 · Oncotarget
Rationale for RAS Mutation-Tailored Therapies
Steven K. Montalvo, Lianbo Li, Kenneth D. Westover · 2016 · Future Oncology
Differentiation and Inflammation: ‘Best Enemies’ in Gastrointestinal Carcinogenesis
Nathan M. Krah, Lewis Charles Murtaugh · 2016 · Trends in cancer
Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers
Małgorzata Milewska, Mattia Cremona, Clare Morgan, John O’Shea, Aoife Carr, Sri HariKrishna Vellanki, Ann M. Hopkins, Sinéad Toomey, Stephen F. Madden, Bryan T. Hennessy et al. · 2018 · Therapeutic Advances in Medical Oncology
Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics
Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos‐Delgado, Céline Basset, Benoît Thibault, Julie Guillermet‐Guibert · 2018 · Cancers
RET, a targetable driver of pancreatic adenocarcinoma
Moran Amit, Shorook Na’ara, Eran Fridman, Euvgeni Vladovski, Tanya Wasserman, Neta Milman, Ziv Gil · 2018 · International Journal of Cancer
Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
Yolanda Rodrı́guez Gil, Paula Jiménez Sánchez, Raúl Muñoz Velasco, Ana García García, Victor Javier Sanchez-Arevalo Lobo · 2021 · International Journal of Molecular Sciences
Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study
Ada Aita, Caterina Millino, Cosimo Sperti, Beniamina Pacchioni, Mario Plebani, Cristiano De Pittà, Daniela Basso · 2021 · Biomedicines
Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma
James M. Cleary, Brian M. Wolpin, Stephanie K. Dougan, Srivatsan Raghavan, Harshabad Singh, Brandon M. Huffman, Nilay S. Sethi, Jonathan Andrew Nowak, Geoffrey Ira Shapiro, Andrew J. Aguirre et al. · 2021 · Clinical Cancer Research
Models of pancreatic ductal adenocarcinoma
Rayane Dennaoui, Hridaya Shrestha, Kay-Uwe Wagner · 2021 · Cancer Metastasis Review
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples
Miriam Redegalli, Greta Grassini, Gilda Magliacane, Lorenza Pecciarini, Marco Schiavo Lena, Chanel Elisha Smart, Rebecca L. Johnston, Nicola Waddell, Roberta Maestro, Marina Macchini et al. · 2022 · Clinical Gastroenterology and Hepatology
SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents
Jean M. Davidson, Zhewei Shen, Xue Gong, Jonathan R. Pollack · 2017 · Oncotarget
Team work and cytopathology molecular diagnosis of solid pancreatic lesions
Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli et al. · 2017 · Digestive Endoscopy
MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell–intrinsic Amplification of Type I IFN Signaling
Razmik Ghukasyan, Keke Liang, Kevin Chau, Luyi Li, Charlotte Chan, Evan R. Abt, Thuc M. Le, Joon Y. Park, Nanping Wu, Alykhan Premji et al. · 2023 · Clinical Cancer Research
Tumor Microenvironment Role in Pancreatic Cancer Stem Cells
Aaron Galindo-Vega, Vilma Maldonado, Irma Beatriz Mitre-Aguilar, Jorge Meléndez-Zajgla · 2023 · Cells
Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma
Xing Wang, Jinshou Yang, Bo Ren, Gang Yang, Xiaohong Liu, Ruiling Xiao, Jie Ren, Feihan Zhou, Lei You, Yupei Zhao · 2023 · Genes & Diseases
The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis
Jing Jing Li, Cheok Soon Lee · 2023 · Genes
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
Charlotte Maulat, Cindy Canivet, Bastien Cabarrou, Anne Pradines, Janick Sèlves, Anne Casanova, Aurélia Doussine, Naïma Hanoun, Emmanuel Cuellar, Paul Boulard et al. · 2024 · Scientific Reports
NUMB alternative splicing and isoform-specific functions in development and disease
Sascha E. Dho, Kamal Othman, Yangjing Zhang, C. Jane McGlade · 2025 · Journal of Biological Chemistry
Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?
Min Yuen Teo, Eileen Mary O'Reilly · 2016 · Journal of Gastrointestinal Oncology
Integrated analysis of mRNA and miRNA expression profiles in pancreatic ductal adenocarcinoma
Hongwei Sun, Liang Yu Zhao, Kehua Pan, Zhao Zhang, Mengtao Zhou, Guoquan Cao · 2017 · Oncology Reports
The origins and consequences of UPF1 variants in pancreatic adenosquamous carcinoma
Jacob Tyler Polaski, Dylan B. Udy, Luisa F. Escobar‐Hoyos, Gokce Askan, Steven D. Leach, Andrea Ventura, Ram Kannan, Robert K. Bradley · 2021 · eLife
Combination of miR‑143 and miR‑506 reduces lung and pancreatic cancer cell growth through the downregulation of cyclin‑dependent kinases
A K M Nawshad Hossian, Gerardo Guillermo Mackenzie, George Mattheolabakis · 2021 · Oncology Reports
Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
Sofia Parrasia, Mario Zoratti, Ildikò Szabó, Lucia Biasutto · 2020 · Cellular Physiology and Biochemistry
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer
Frank Arnold, Johann Gout, Heike Wiese, Stephanie Ellen Weissinger, Élodie Roger, Lukas Perkhofer, Karolin Walter, Jeanette Scheible, Caterina Prelli Bozzo, André Lechel et al. · 2021 · Cancer Research
Future directions in drug development in pancreatic cancer
Aurélien Lambert, Thierry Conroy, Michel Pierre Ducreux · 2021 · Seminars in Oncology
Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer
Ji Eun Lee, Min Gyu Woo, Kyung Hee Jung, Yeo Wool Kang, Seungmin Shin, Mi Kwon Son, Zhenghuan Fang, HONG HUA YAN, Jung Hee Park, Young‐Chan Yoon et al. · 2021 · Biomolecules & Therapeutics
Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report
Ziyao Wang, He Du, Chen Chen, Xubao Liu, Nengwen Ke · 2022 · Frontiers in Oncology
Lycorine upregulates the expression of RMB10, promotes apoptosis and inhibits the proliferation and migration of cervical cancer cells
Zi‐Zhan Li, Qin Zhou, Xianguang Liu, Yaohua Li, Xinli Fan, Gangli Liu · 2022 · International Journal of Molecular Medicine
Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors
Chien‐Feng Li, I‐Chieh Chuang, Tingting Liu, Ko–Chin Chen, Yen‐Yang Chen, Fu‐Min Fang, Shau-Hsuan Li, Tzu‐Ju Chen, Shih-Chen Yu, Jui Lan et al. · 2016 · Oncotarget
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
Julian C. Bahr, Robert W. Robey, Victoria L. Luchenko, Agnès Basseville, Arup R. Chakraborty, Hanna Kozlowski, Gary T. Pauly, Paresma Patel, Joel P. Schneider, Michael M. Gottesman et al. · 2016 · Oncotarget
Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
Ashton Anthony Connor, Steve Gallinger · 2017 · Expert Review of Gastroenterology & Hepatology
Modeling of RAS complexes supports roles in cancer for less studied partners
Hatice Billur Engin, Daniel E. Carlin, Dexter R. Pratt, Hannah K. Carter · 2017 · BMC Biophysics
Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset
Jeffery Ho, Xiangchun Li, Lin Zhang, Yonghao Liang, Wei Hu, Johnny Chung Wai Yau, Hung Chan, Tony Gin, Matthew T.V. Chan, Gary Tse et al. · 2018 · Seminars in Cancer Biology
E47 Governs the MYC-CDKN1B/p27 KIP1 -RB Network to Growth Arrest PDA Cells Independent of CDKN2A/p16 INK4A and Wild-Type p53
Kathleen M. Scully, Reyhaneh Lahmy, Lia Signaevskaia, Roman Šášik, Rachel Medal, Hee Jung Kim, Randall P. French, Brian P. James, Yifan Wu, Andrew M. Lowy et al. · 2018 · Cellular and Molecular Gastroenterology and Hepatology
Prognostic and Clinicopathological Significance of SERTAD1 in Various Types of Cancer Risk: A Systematic Review and Retrospective Analysis
Raj Kumar Mongre, Samil Jung, Chandra Bhushan Mishra, Beom Suk Lee, Shikha Kumari, Myeong‐Sok Lee · 2019 · Cancers